Literature DB >> 31266594

Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia.

Roberto Cangemi1, Camilla Calvieri2, Gloria Taliani3, Pasquale Pignatelli1, Sergio Morelli1, Marco Falcone4, Daniele Pastori1, Francesco Violi5.   

Abstract

Atrial fibrillation (AF) is one of the most common cardiovascular complications in patients hospitalized with community-acquired pneumonia (CAP). However, predisposing clinical factors associated with AF in CAP patients have not been fully elucidated. We enrolled 545 patients consecutively hospitalized for CAP. Data on demographic characteristics and co-morbidities were collected and all patients underwent ECG, echocardiography, and laboratory measurements. During the in-hospital stay, 9.5% of patients experienced a new episode of AF within 24 to 72 hours from admission. CAP patients who experienced AF had a higher indexed left atrial area (LAAi) and a higher proportion of concentric left ventricular hypertrophy than those not presenting AF. Univariate logistic regression analysis showed that hypertension, history of coronary heart disease, high Pneumonia Severity Index classes, history of paroxysmal AF, systolic heart failure, concentric left ventricular hypertrophy, and an enlarged LAAi were associated with a new episode of AF. A multivariable logistic analysis showed that history of paroxysmal AF (odds ratio [OR] 11.7; 95% confidence interval [CI] 5.8 to 23.7; p <0.001), enlarged LAAi (OR 5.4; 95% CI 2.5 to 11.9; p <0.001), and concentric left ventricular hypertrophy (OR 2.2; 95 CI 1.1 to 4.6; p = 0.034) remained independently associated with AF occurrence. In conclusion, in this large cohort of CAP patients, history of paroxysmal AF, enlarged LAAi, and concentric left ventricular hypertrophy are independent predictors of AF occurrence during the early stages of pneumonia.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31266594     DOI: 10.1016/j.amjcard.2019.05.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Novel effects of acute COVID-19 on cardiac mechanical function: Two case studies.

Authors:  Jyotpal Singh; Lanishen Bhagaloo; Eric Sy; Andrea J Lavoie; Payam Dehghani; Patrick Neary
Journal:  Physiol Rep       Date:  2021-09

2.  Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis.

Authors:  Sebastiano Cicco; Vanessa Desantis; Antonio Vacca; Gerardo Cazzato; Antonio G Solimando; Anna Cirulli; Silvia Noviello; Cecilia Susca; Marcella Prete; Gabriele Brosolo; Cristiana Catena; Aurelia Lamanuzzi; Ilaria Saltarella; Maria Antonia Frassanito; Antonella Cimmino; Giuseppe Ingravallo; Leonardo Resta; Roberto Ria; Monica Montagnani
Journal:  Front Med (Lausanne)       Date:  2022-05-16

Review 3.  Cardiovascular Events After Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies.

Authors:  António Tralhão; Pedro Póvoa
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

4.  Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.

Authors:  Francesco Violi; Giancarlo Ceccarelli; Roberto Cangemi; Francesco Cipollone; Damiano D'Ardes; Alessandra Oliva; Matteo Pirro; Monica Rocco; Francesco Alessandri; Gabriella D'Ettorre; Miriam Lichtner; Pasquale Pignatelli; Domenico Ferro; Franco Ruberto; Gregory Y H Lip; Francesco Pugliese; Claudio Maria Mastroianni
Journal:  Intern Emerg Med       Date:  2021-07-04       Impact factor: 3.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.